• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[取代环糊精:仿生催化剂的一个实例]

[Substituted cyclodextrins: an example of biomimetic catalyzers].

作者信息

Masurier N, Lafont O, Estour F

机构信息

Umr 6014, Cnrs, Université de Rouen, INSA de Rouen, Laboratoire de pharmacochimie, Ufr de médecine et de pharmacie, 22, boulevard Gambetta, F 76183 Rouen.

出版信息

Ann Pharm Fr. 2007 Mar;65(2):126-33.

PMID:17404546
Abstract

Among all molecules used to develop biomimetic catalysts, cyclodextrins are extremely attractive compounds. These oligosaccharides can form inclusion complexes with various organic substrates and in particular with organophosphorus poisons, which are widely used as chemical weapons and insecticides. Soman, a frightening neurotoxic agent, once "trapped" in the internal cavity of beta-cyclodextrin can moreover undergo the nucleophilic attack of an oligosaccharide hydroxyl group, miming the first step of the enzymatic process. Selective substitution of beta-cyclodextrin by a 2-iodosobenzoic acid derivative has enabled effective synthesis of scavangers against organophosphorus compounds. Hydrolysis trials were carried out with paraoxon, as an organophosphorus model. The OP-hydrolyzing activity could reach more than two order of magnitude compared with free 2-iodosobenzoïc acid. Nevertheless, hydrolysis of paraoxon showed saturation kinetics. Although the activity was strongly dependent on the relative position of the reactive group, these results showed the interest of a strategy, resulting in the "trapping" of the organophosphorus substrate in the internal cavity of the oligosaccharide in order to maintain it near the catalytic function.

摘要

在所有用于开发仿生催化剂的分子中,环糊精是极具吸引力的化合物。这些寡糖能与各种有机底物形成包合物,尤其是与作为化学武器和杀虫剂广泛使用的有机磷毒物。索曼,一种可怕的神经毒剂,一旦“被困”在β-环糊精的内腔中,还能经历寡糖羟基的亲核攻击,模拟酶促过程的第一步。用2-碘苯甲酸衍生物对β-环糊精进行选择性取代,已能有效合成针对有机磷化合物的清除剂。以对氧磷作为有机磷模型进行了水解试验。与游离的2-碘苯甲酸相比,OP水解活性可达到两个以上数量级。然而,对氧磷的水解表现出饱和动力学。尽管活性强烈依赖于反应基团的相对位置,但这些结果表明了一种策略的意义,即通过将有机磷底物“捕获”在寡糖的内腔中,使其保持在催化功能附近。

相似文献

1
[Substituted cyclodextrins: an example of biomimetic catalyzers].[取代环糊精:仿生催化剂的一个实例]
Ann Pharm Fr. 2007 Mar;65(2):126-33.
2
Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.具有针对有机磷酸酯对氧磷水解活性的2-取代β-环糊精衍生物的合成。
Eur J Med Chem. 2005 Jul;40(7):615-23. doi: 10.1016/j.ejmech.2005.02.008. Epub 2005 Apr 1.
3
Remarkable supramolecular catalysis of glycoside hydrolysis by a cyclodextrin cyanohydrin.环糊精氰醇对糖苷水解的显著超分子催化作用。
J Am Chem Soc. 2005 Mar 16;127(10):3238-9. doi: 10.1021/ja042678a.
4
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.功能化环糊精带有一个α亲核试剂——一种有前途的神经毒剂降解方法。
Chem Biol Interact. 2013 Mar 25;203(1):202-7. doi: 10.1016/j.cbi.2012.10.020. Epub 2012 Nov 2.
5
Conjugate of palladium(II) complex and beta-cyclodextrin acts as a biomimetic peptidase.钯(II)配合物与β-环糊精的共轭物可作为一种仿生肽酶。
J Am Chem Soc. 2004 Jan 28;126(3):696-7. doi: 10.1021/ja038404p.
6
Cyclodextrin aldehydes are oxidase mimics.环糊精醛是氧化酶模拟物。
Chembiochem. 2009 Oct 12;10(15):2494-503. doi: 10.1002/cbic.200900448.
7
Ring-opening polymerization of cyclic esters by cyclodextrins.环糊精催化环状酯的开环聚合反应。
Acc Chem Res. 2008 Sep;41(9):1143-52. doi: 10.1021/ar800079v. Epub 2008 Aug 9.
8
Cyclodextrin-based bioactive supramolecular assemblies.基于环糊精的生物活性超分子组装体。
Chem Soc Rev. 2010 Feb;39(2):495-505. doi: 10.1039/b816354p. Epub 2009 Sep 16.
9
Cyclodextrin retinylidene: a biomimetic kinetic trap model for rhodopsin.环糊精视黄叉:一种用于视紫红质的仿生动力学陷阱模型。
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1523-6. doi: 10.1016/j.bmcl.2005.12.052. Epub 2005 Dec 27.
10
Cyclodextrin trimers as receptors for arranging ester and catalyst at optimized location to achieve enhancement of hydrolytic activity.
Bioorg Med Chem Lett. 2004 Apr 5;14(7):1783-6. doi: 10.1016/j.bmcl.2004.01.035.